Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular EventsS. Matthijs Boekholdt, J. Wouter Jukema, Ron J.G. Peters et al.|Circulation|2003Cited by 226